Precision Medicine in Oncology® | Specialty

The OncLive Precision Medicine in Oncology® condition center page is a comprehensive resource for clinical news and expert insights on precision-focused approaches in patients with cancer, with gene-targeted tyrosine kinase inhibitors and antibody-drug conjugates, checkpoint inhibitors, tumor-infiltrating lymphocyte therapy, and other tailored treatments. This page features news articles, interviews in written and video format, and podcasts that focus on updates and ongoing research with personalized therapies across solid and hematologic tumors.

HER2+ Breast Cancer: Evolution of Antibody-Drug Conjugates

January 11th 2020

Unmet Needs in the Management of HER2+ mBC

January 11th 2020

Treatment Strategies for Relapsed/Refractory HER2+ mBC

January 11th 2020

HER2+ BC: Selection and Management of Neoadjuvant Therapy

January 11th 2020

Overview of Neoadjuvant Therapy in HER2+ Breast Cancer

January 11th 2020

Early-Stage HER2+ Breast Cancer: The ATEMPT Trial

January 11th 2020

Impact of the KATHERINE Trial on Early-Stage HER2+ BC

January 11th 2020

Adjuvant Strategies in Early-Stage HER2+ Breast Cancer

January 11th 2020

Evolving Landscape of HER2-Targeted Therapy in Breast Cancer

January 11th 2020

Dr. Goetz on the Use of ctDNA in the MONARCH-3 Trial in HR+/HER2- Breast Cancer

January 9th 2020

Matthew P. Goetz, MD, Mayo Clinic, discusses the use of circulating tumor DNA in the phase III MONARCH-3 trial in hormone receptor–positive, HER2-negative breast cancer.

Dr. Paulson on the Utility of Liquid Biopsies Versus Tissue Biopsies

January 9th 2020

R. Steven Paulson, MD, discusses the utility of liquid biopsies versus tissue biopsies.

Current Advancements in HER2+ Breast Cancer Management

December 24th 2019

HER2CLIMB-02 Trial Regimen Toxicities and Impact

December 24th 2019

The HER2CLIMB-02 Trial Design, Results and Implications

December 24th 2019

HER2+ Breast Cancer: Brain Metastasis Prevalence & Later-Line Therapy

December 24th 2019

Emerging Data for the Treatment of HER2+ mBC

December 24th 2019

HER2+ mBC: Systemic Therapies and HER2CLIMB-02 Trial

December 24th 2019

Management of CNS Metastases in R/R HER2+ mBC

December 24th 2019

HER2+ Metastatic Breast Cancer: Standard of Care Therapies

December 24th 2019

Precision Medicine Propels Research Efforts in Breast Cancer

December 5th 2019

Mark E. Robson, MD, provides a snapshot of the precision focus in breast cancer, as well as the emergence of biosimilars in the field.